BMEZ News and Press, BlackRock Health Sciences Trust II of Beneficial Interest From 04/11/21

There are three primary things that I see a lot of newer CEF investors get hung up on; return of capital, section 19a and data aggregators distribution classifications. All three of these have to do with the tax character of the distributions and the mistakes that can be made. The...

The fund just received a huge distribution boost, making it more appealing to income-oriented investors. The latest declines in BMEZ also coincide with an attractive discount on the fund. BMEZ is an attractive long-term option in the healthcare space that focuses on new tech - tho...

Since around 2007, the number of closed-end funds available on the market has been shrinking. These often income-oriented investment vehicles are now down to around 488 funds, and this number is about to go lower. Overall, this isn't a bad thing as it has primarily been coming fro...

BlackRock Health Sciences Trust II (BMEZ) declares $0.145/share monthly dividend, in line with previous.Forward yield 6.3%Payable March 31; for shareholders of record March 15; ex-div March 12.See BMEZ Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Blac...

Twenty-two out of 23 CEF sectors positive on price and 21 out of 23 sectors positive on NAV last week. MLPs lead while commodities lag. Limited duration is the highest-yielding CEF sector. For further details see: Weekly Closed-End Fund Roundup: February 7, 2021

BMEZ delivered solid results throughout 2020, helped by the healthcare sector overall. This fund doesn't just invest in your typical healthcare companies though and tilts towards smaller and private investments. These companies are ripe for significant growth, at the same time, BM...

BMEZ is a CEF that's ~1 year old - it pays monthly and yields 4.1%. It's trading at a 7.39% discount to NAV. It focuses on cutting edge life sciences stocks and private investments. For further details see: 7% Discount, 4% Yield, Next-Generation Healthcare: BlackRock Hea...

BCAT was launched several months ago on September 25th, 2020. Now that we have a few months of data to go off of, I wanted to check out the fund. The fund is interesting in how flexible it is, but quickly jumped to a premium valuation and has stayed there. For further detail...

16 out of 23 CEF sectors positive on price and 14 out of 23 sectors positive on NAV last week. MLPs lead while preferreds/real estate lags. PPR tender results: decent pro-ration factor with quick +8% gain on tendered shares in our Tactical Income-100 portfolio. For further d...

17 out of 23 CEF sectors positive on price and 19 out of 23 sectors positive on NAV last week. PPR tender offer expires on January 4, 2021, and our Tactical Income-100 portfolio is tendering all shares. NHF's extended tender offer also expired. For further details see: W...